TrialDiabetes care2011

Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans.

Daniël H van Raalte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.